X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.contractpharma.com/contents/view_breaking-news/2024-06-20/morphosys-to-delist-from-frankfurt-stock-exchange-nasdaq-following-novartis-acquisition/9769
https://www.biopharmadive.com/news/erasca-layoffs-breyanzi-approval-morphosys-novartis/716290/
https://www.globenewswire.com/news-release/2024/05/16/2883195/0/en/Novartis-meets-all-tender-offer-conditions-to-acquire-MorphoSys-AG-for-EUR-68-per-share-in-cash.html
https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-buy-radiology-specialist-mariana-oncology-1-billion-2024-05-02/
https://www.reuters.com/markets/deals/morphosys-says-novartis-takeover-progressing-planned-h1-2024-2024-04-29/#:~:text=Morphosys\'%20statement%20came%20after%20a,cancer%20affecting%20the%20bone%20marrow.
https://www.accesswire.com/856134/morphosys-to-present-new-phase-3-manifest-2-data-on-pelabresib-in-myelofibrosis-in-oral-presentation-at-2024-asco-annual-meeting
https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-begins-tender-offer-morphosys-2024-04-11/
https://www.globenewswire.com/news-release/2024/04/11/2861280/0/en/Novartis-tender-offer-for-MorphoSys-AG-commences.html
Market Place
Share 
